1. Am J Respir Cell Mol Biol. 2022 Apr;66(4):349-350. doi: 
10.1165/rcmb.2021-0405ED.

First Steps toward Personalized Therapies for ABCA3 Deficiency.

Wambach JA(1), Nogee LM(2), Cole FS(1).

Author information:
(1)Edward Mallinckrodt Department of Pediatric Washington University School of 
Medicine St. Louis, Missouri.
(2)Department of Pediatrics Johns Hopkins University School of Medicine 
Baltimore, Maryland.

Comment on
    Am J Respir Cell Mol Biol. 2022 Apr;66(4):382-390. doi: 
10.1165/rcmb.2021-0223OC.

DOI: 10.1165/rcmb.2021-0405ED
PMCID: PMC8990116
PMID: 35077664 [Indexed for MEDLINE]